NCT06706466View on ClinicalTrials.gov

Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy.

CompletedOBSERVATIONAL
Enrollment

410

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2021

Study Completion Date

May 1, 2024

Conditions
Immunotherapy Gastrict CancerInflammation BiomarkersGastric Cancers
Interventions
OTHER

observational study

Non-interventional

Trial Locations (1)

351100

Fujian Medical University Union Hospital, Fuzhou

All Listed Sponsors
lead

Chang-Ming Huang, Prof.

OTHER

NCT06706466 - Evaluate the Prognostic Significance of Changes in the Systemic Immune-Inflammation Index in Patients with AGC Treated with ICI Therapy. | Biotech Hunter | Biotech Hunter